Depression News and Research

Latest Depression News and Research

Light-cell interaction and Born approximation rule can help detect misshapen red blood cells

Misshapen red blood cells are a sign of serious illnesses, such as malaria and sickle cell anemia. Until recently, the only way to assess whether a person's RBCs were the correct shape was to look at them individually under a microscope - a time-consuming process for pathologists.

1 Nov 2011

Even without depression, obesity raises health costs in Group Health study

Obesity and depression both dramatically increase health care costs, but they mainly act separately, according to a study published in the November 2011 Journal of General Internal Medicine by Group Health Research Institute scientists.

1 Nov 2011

Teen study reveals unhealthy and concerning trends

An alarming trend shows that girls as young as primary-school age are increasingly troubled by their self-image, with more than a third of those aged between 10 and 11 eager to lose weight and adopting drastic methods to pursue their ideal body shape.

31 Oct 2011

Good digestive health may help regulate and reduce stress in the brain

Good digestive health may help to regulate and reduce stress in the brain, according to a recent study out of University College Cork in Cork, Ireland and featured in the October issue of Food Nutrition & Science.

31 Oct 2011

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

31 Oct 2011

Researchers identify FMRP protein as key player in RNA editing

The most common form of heritable cognitive impairment is Fragile X Syndrome, caused by mutation or malfunction of the FMR1 gene. Loss of FMR1 function is also the most common genetic cause of autism. Understanding how this gene works is vital to finding new treatments to help Fragile X patients and others.

31 Oct 2011

'Deep sequencing' technology identifies new target area for depression

Scientists at the Texas Biomedical Research Institute and Yale University have identified a new target area in the human genome that appears to harbor genes with a major role in the onset of depression.

29 Oct 2011

Twelve students participate in Hartford Doctoral Fellows Program in Geriatric Social Work

Twelve outstanding students have been chosen as the newest participants in the Hartford Doctoral Fellows Program in Geriatric Social Work. The program is funded by the John A. Hartford Foundation, administered by The Gerontological Society of America, and directed by James Lubben, DSW, MPH.

29 Oct 2011

Chronic pain may increase risk of suicide ideation in adolescents

Chronic pain in adolescents is a risk factor for suicide ideation, according to new research reported in The Journal of Pain, published by American Pain Society.

28 Oct 2011

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

New potential leukemia therapy targets and kills cancer cells

A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.

27 Oct 2011

Study: Depressive symptoms linked to negative health risks among asthma patients

People with asthma are more likely to have symptoms of depression. A new study suggests these symptoms are linked to a host of other negative health risks that may lead to a worsening of asthma symptoms and an overall decline in health.

27 Oct 2011

No link between Chantix and mental health problems says FDA

According to federal health officials this Monday Pfizer's anti-smoking drug Chantix – known as Varenicline, did not increase psychiatric problems like depression and suicidal thoughts in two studies, though the findings are not definitive.

25 Oct 2011

Three dry days a week reduces risk of alcohol related liver disease

The Royal College of Physicians said the present official guidance on healthy drinking limits is ‘extremely dangerous’ and must be rewritten – because it implies that drinking every day is fine. Government advice states men should drink no more than four units a day and women no more than three.

24 Oct 2011

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

24 Oct 2011

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Comprehensive Care Corporation, which provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S., today announced that it has acquired exclusive distribution rights to an innovative patented product aimed directly at reducing depression in individuals resulting from chronic back pain.

24 Oct 2011

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark, announced today that the U.S. Food and Drug Administration (FDA) has approved ONFI as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients two years and older.

24 Oct 2011

Depression News and Research

Latest Depression News and Research

Light-cell interaction and Born approximation rule can help detect misshapen red blood cells

Even without depression, obesity raises health costs in Group Health study

Teen study reveals unhealthy and concerning trends

Good digestive health may help regulate and reduce stress in the brain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Researchers identify FMRP protein as key player in RNA editing

'Deep sequencing' technology identifies new target area for depression

Twelve students participate in Hartford Doctoral Fellows Program in Geriatric Social Work

Chronic pain may increase risk of suicide ideation in adolescents

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

New potential leukemia therapy targets and kills cancer cells

Study: Depressive symptoms linked to negative health risks among asthma patients

No link between Chantix and mental health problems says FDA

Three dry days a week reduces risk of alcohol related liver disease

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

First Edition: October 24, 2011

Holtorf Medical Group opens new affiliate center in King of Prussia, Pennsylvania

E-counselling can lower blood pressure and enhance quality of life

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Depression News and Research

Latest Depression News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in